Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.27
USPH's Cash-to-Debt is ranked lower than
53% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. USPH: 0.27 )
Ranked among companies with meaningful Cash-to-Debt only.
USPH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.17  Med: 0.74 Max: No Debt
Current: 0.27
Equity-to-Asset 0.47
USPH's Equity-to-Asset is ranked higher than
51% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. USPH: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
USPH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27  Med: 0.68 Max: 0.97
Current: 0.47
0.27
0.97
Debt-to-Equity 0.39
USPH's Debt-to-Equity is ranked higher than
63% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 0.57 vs. USPH: 0.39 )
Ranked among companies with meaningful Debt-to-Equity only.
USPH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.22 Max: 2.18
Current: 0.39
0
2.18
Interest Coverage 2.37
USPH's Interest Coverage is ranked lower than
75% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.41 vs. USPH: 2.37 )
Ranked among companies with meaningful Interest Coverage only.
USPH' s Interest Coverage Range Over the Past 10 Years
Min: 2.37  Med: 64.96 Max: 140.64
Current: 2.37
2.37
140.64
Piotroski F-Score: 3
Altman Z-Score: 4.01
Beneish M-Score: -2.46
WACC vs ROIC
9.09%
17.36%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 13.36
USPH's Operating Margin % is ranked higher than
71% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. USPH: 13.36 )
Ranked among companies with meaningful Operating Margin % only.
USPH' s Operating Margin % Range Over the Past 10 Years
Min: 12.72  Med: 14.16 Max: 15.71
Current: 13.36
12.72
15.71
Net Margin % 4.70
USPH's Net Margin % is ranked higher than
56% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. USPH: 4.70 )
Ranked among companies with meaningful Net Margin % only.
USPH' s Net Margin % Range Over the Past 10 Years
Min: 4.7  Med: 6.04 Max: 9.06
Current: 4.7
4.7
9.06
ROE % 9.67
USPH's ROE % is ranked higher than
58% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. USPH: 9.67 )
Ranked among companies with meaningful ROE % only.
USPH' s ROE % Range Over the Past 10 Years
Min: 9.67  Med: 13.94 Max: 19.88
Current: 9.67
9.67
19.88
ROA % 5.03
USPH's ROA % is ranked higher than
65% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. USPH: 5.03 )
Ranked among companies with meaningful ROA % only.
USPH' s ROA % Range Over the Past 10 Years
Min: 5.03  Med: 9.79 Max: 13.79
Current: 5.03
5.03
13.79
ROC (Joel Greenblatt) % 120.48
USPH's ROC (Joel Greenblatt) % is ranked higher than
89% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 16.07 vs. USPH: 120.48 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
USPH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 45.91  Med: 117.73 Max: 149.88
Current: 120.48
45.91
149.88
3-Year Revenue Growth Rate 9.30
USPH's 3-Year Revenue Growth Rate is ranked higher than
55% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. USPH: 9.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
USPH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.1  Med: 13.8 Max: 100.8
Current: 9.3
7.1
100.8
3-Year EBITDA Growth Rate 8.40
USPH's 3-Year EBITDA Growth Rate is ranked higher than
53% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. USPH: 8.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
USPH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -24.2  Med: 12.95 Max: 27.3
Current: 8.4
-24.2
27.3
3-Year EPS without NRI Growth Rate 4.20
USPH's 3-Year EPS without NRI Growth Rate is ranked lower than
57% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 7.50 vs. USPH: 4.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
USPH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -1.2  Med: 13.35 Max: 57.8
Current: 4.2
-1.2
57.8
GuruFocus has detected 4 Warning Signs with US Physical Therapy Inc $USPH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» USPH's 30-Y Financials

Financials (Next Earnings Date: 2017-11-10 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

USPH Guru Trades in Q3 2016

Joel Greenblatt 5,232 sh (New)
Jim Simons 573,654 sh (-0.26%)
Chuck Royce 318,425 sh (-0.81%)
» More
Q4 2016

USPH Guru Trades in Q4 2016

Jim Simons 591,700 sh (+3.15%)
Joel Greenblatt Sold Out
Chuck Royce 317,825 sh (-0.19%)
» More
Q1 2017

USPH Guru Trades in Q1 2017

Jim Simons 605,000 sh (+2.25%)
Chuck Royce 317,825 sh (unchged)
» More
Q2 2017

USPH Guru Trades in Q2 2017

Jim Simons 668,074 sh (+10.43%)
Chuck Royce 317,825 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with USPH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2016-12-31 Sold Out $53.2 - $71.55 $ 58.75-8%0
Joel Greenblatt 2016-09-30 New Buy$58.45 - $64.69 $ 58.75-5%5,232
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621498    SIC: 8093
Compare:NAS:PRSC, NAS:AFAM, NYSE:CYH, NAS:SGRY, NAS:ADUS, NAS:BIOS, NAS:LHCG, NYSE:AAC, OTCPK:AVCO, NYSE:QHC, AMEX:HLTH, TSXV:IOM, OTCPK:NVOS, NAS:CATS, NAS:JYNT, OTCPK:AMEH, OTCPK:CCEL, OTCPK:FCHS, OTCPK:MIHI, OTCPK:BICX » details
Traded in other countries:UPH.Germany,
Headquarter Location:USA
US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics across US which provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries.

US Physical Therapy operates outpatient physical therapy and occupational therapy clinics throughout the United States. Its clinics provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. The company also administers care designed to prevent injuries from occurring. At the start of 2002, the company operated 170 clinics in more than 30 states.

Top Ranked Articles about US Physical Therapy Inc

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against U.S. Physical Therapy, Inc. (USPH) & Lead Plaintiff Deadline – May 30, 2017
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In U.S. Physical Therapy, Inc. To Contact The Firm
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against U.S. Physical Therapy, Inc. - USPH
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of U.S. Physical Therapy, Inc. Shareholders and a Lead Plaintiff Deadline of May 30, 2017
USPH SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving U.S. Physical Therapy, Inc. and a Lead Plaintiff Deadline of May 30, 2017
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against U.S. Physical Therapy, Inc. and Reminds Investors with Losses to Contact the Firm
USPH LOSS ALERT: Rosen Law Firm Reminds U.S. Physical Therapy, Inc. Investors of Important Deadline in Class Action - USPH
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against U.S. Physical Therapy, Inc. and Reminds Investors with Losses to Contact the Firm
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In U.S. Physical Therapy, Inc. (NYSE: USPH) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against U.S. Physical Therapy, Inc. and Encourages Investors with Losses to Contact the Firm

Ratios

vs
industry
vs
history
PE Ratio 41.36
USPH's PE Ratio is ranked lower than
70% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 26.05 vs. USPH: 41.36 )
Ranked among companies with meaningful PE Ratio only.
USPH' s PE Ratio Range Over the Past 10 Years
Min: 8.91  Med: 20.35 Max: 50.34
Current: 41.36
8.91
50.34
Forward PE Ratio 25.25
USPH's Forward PE Ratio is ranked lower than
77% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 21.05 vs. USPH: 25.25 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 41.36
USPH's PE Ratio without NRI is ranked lower than
70% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. USPH: 41.36 )
Ranked among companies with meaningful PE Ratio without NRI only.
USPH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.91  Med: 19.23 Max: 50.34
Current: 41.36
8.91
50.34
Price-to-Owner-Earnings 35.63
USPH's Price-to-Owner-Earnings is ranked higher than
58% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 27.37 vs. USPH: 35.63 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
USPH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.5  Med: 20.67 Max: 60.43
Current: 35.63
5.5
60.43
PB Ratio 3.79
USPH's PB Ratio is ranked lower than
68% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. USPH: 3.79 )
Ranked among companies with meaningful PB Ratio only.
USPH' s PB Ratio Range Over the Past 10 Years
Min: 1.12  Med: 2.68 Max: 5.01
Current: 3.79
1.12
5.01
PS Ratio 1.93
USPH's PS Ratio is ranked lower than
58% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.69 vs. USPH: 1.93 )
Ranked among companies with meaningful PS Ratio only.
USPH' s PS Ratio Range Over the Past 10 Years
Min: 0.49  Med: 1.24 Max: 2.63
Current: 1.93
0.49
2.63
Price-to-Free-Cash-Flow 21.56
USPH's Price-to-Free-Cash-Flow is ranked higher than
66% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 24.30 vs. USPH: 21.56 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
USPH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.33  Med: 10.39 Max: 23.99
Current: 21.56
3.33
23.99
Price-to-Operating-Cash-Flow 17.46
USPH's Price-to-Operating-Cash-Flow is ranked higher than
52% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 15.16 vs. USPH: 17.46 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
USPH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.83  Med: 8.77 Max: 19.41
Current: 17.46
2.83
19.41
EV-to-EBIT 15.60
USPH's EV-to-EBIT is ranked higher than
67% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 20.05 vs. USPH: 15.60 )
Ranked among companies with meaningful EV-to-EBIT only.
USPH' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.9  Med: 9 Max: 19.6
Current: 15.6
3.9
19.6
EV-to-EBITDA 13.18
USPH's EV-to-EBITDA is ranked higher than
61% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 15.41 vs. USPH: 13.18 )
Ranked among companies with meaningful EV-to-EBITDA only.
USPH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.1  Med: 7.8 Max: 16.6
Current: 13.18
3.1
16.6
EV-to-Revenue 2.08
USPH's EV-to-Revenue is ranked higher than
51% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. USPH: 2.08 )
Ranked among companies with meaningful EV-to-Revenue only.
USPH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.5  Med: 1.3 Max: 2.7
Current: 2.08
0.5
2.7
PEG Ratio 6.76
USPH's PEG Ratio is ranked lower than
78% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 3.06 vs. USPH: 6.76 )
Ranked among companies with meaningful PEG Ratio only.
USPH' s PEG Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.63 Max: 7.24
Current: 6.76
0.8
7.24
Shiller PE Ratio 41.17
USPH's Shiller PE Ratio is ranked lower than
65% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 29.00 vs. USPH: 41.17 )
Ranked among companies with meaningful Shiller PE Ratio only.
USPH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 11.61  Med: 26.29 Max: 54.74
Current: 41.17
11.61
54.74
Current Ratio 2.26
USPH's Current Ratio is ranked higher than
78% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. USPH: 2.26 )
Ranked among companies with meaningful Current Ratio only.
USPH' s Current Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.6 Max: 42
Current: 2.26
1.63
42
Quick Ratio 2.26
USPH's Quick Ratio is ranked higher than
80% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. USPH: 2.26 )
Ranked among companies with meaningful Quick Ratio only.
USPH' s Quick Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.6 Max: 42
Current: 2.26
1.63
42
Days Sales Outstanding 50.23
USPH's Days Sales Outstanding is ranked lower than
60% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. USPH: 50.23 )
Ranked among companies with meaningful Days Sales Outstanding only.
USPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.46  Med: 43.99 Max: 64.31
Current: 50.23
40.46
64.31
Days Payable 1.98
USPH's Days Payable is ranked lower than
98% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 44.51 vs. USPH: 1.98 )
Ranked among companies with meaningful Days Payable only.
USPH' s Days Payable Range Over the Past 10 Years
Min: 1.98  Med: 3.19 Max: 4.96
Current: 1.98
1.98
4.96

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.32
USPH's Dividend Yield % is ranked lower than
64% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.67 vs. USPH: 1.32 )
Ranked among companies with meaningful Dividend Yield % only.
USPH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.31  Med: 1.22 Max: 1.74
Current: 1.32
0.31
1.74
Dividend Payout Ratio 0.47
USPH's Dividend Payout Ratio is ranked higher than
81% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 0.39 vs. USPH: 0.47 )
Ranked among companies with meaningful Dividend Payout Ratio only.
USPH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.2  Med: 0.29 Max: 0.47
Current: 0.47
0.2
0.47
3-Year Dividend Growth Rate 19.30
USPH's 3-Year Dividend Growth Rate is ranked higher than
69% of the 81 Companies
in the Global Medical Care industry.

( Industry Median: 10.10 vs. USPH: 19.30 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
USPH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 19.3
Current: 19.3
0
19.3
Forward Dividend Yield % 1.32
USPH's Forward Dividend Yield % is ranked lower than
64% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.95 vs. USPH: 1.32 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.89
USPH's 5-Year Yield-on-Cost % is ranked higher than
55% of the 316 Companies
in the Global Medical Care industry.

( Industry Median: 2.37 vs. USPH: 2.89 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
USPH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.68  Med: 2.67 Max: 3.81
Current: 2.89
0.68
3.81
3-Year Average Share Buyback Ratio 4.40
USPH's 3-Year Average Share Buyback Ratio is ranked higher than
94% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. USPH: 4.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
USPH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -56.9  Med: -0.9 Max: 7.7
Current: 4.4
-56.9
7.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.20
USPH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
73% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 1.97 vs. USPH: 1.20 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
USPH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.38  Med: 0.95 Max: 9.21
Current: 1.2
0.38
9.21
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.86
USPH's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
86% of the 36 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. USPH: 2.86 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
USPH' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.51  Med: 1 Max: 3.26
Current: 2.86
0.51
3.26
Price-to-Median-PS-Value 1.56
USPH's Price-to-Median-PS-Value is ranked lower than
82% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. USPH: 1.56 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
USPH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.48  Med: 1.18 Max: 7.96
Current: 1.56
0.48
7.96
Price-to-Peter-Lynch-Fair-Value 5.64
USPH's Price-to-Peter-Lynch-Fair-Value is ranked lower than
83% of the 59 Companies
in the Global Medical Care industry.

( Industry Median: 2.11 vs. USPH: 5.64 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
USPH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.47  Med: 1.55 Max: 6.78
Current: 5.64
0.47
6.78
Earnings Yield (Greenblatt) % 6.43
USPH's Earnings Yield (Greenblatt) % is ranked higher than
74% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.84 vs. USPH: 6.43 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
USPH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.1  Med: 11.1 Max: 25.9
Current: 6.43
5.1
25.9
Forward Rate of Return (Yacktman) % 12.47
USPH's Forward Rate of Return (Yacktman) % is ranked higher than
55% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: 10.98 vs. USPH: 12.47 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
USPH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 10.6  Med: 19.5 Max: 29.2
Current: 12.47
10.6
29.2

More Statistics

Revenue (TTM) (Mil) $381.02
EPS (TTM) $ 1.42
Beta1.08
Short Percentage of Float3.05%
52-Week Range $51.96 - 78.00
Shares Outstanding (Mil)12.58

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 404 438 473
EPS ($) 2.13 2.40 2.70
EPS without NRI ($) 2.13 2.40 2.70
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)
» More Articles for NYSE:USPH

Headlines

Articles On GuruFocus.com
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against U.S. Ph May 25 2017 
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In U.S. P May 12 2017 
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against U.S. Physic May 11 2017 
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of U.S. Physical Therapy, Inc May 03 2017 
USPH SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involvin May 02 2017 
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against U.S. Physical The Apr 28 2017 
USPH LOSS ALERT: Rosen Law Firm Reminds U.S. Physical Therapy, Inc. Investors of Important Deadline Apr 28 2017 
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against U.S. P Apr 27 2017 
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Inve Apr 26 2017 
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against U.S. Physical Ther Apr 25 2017 

More From Other Websites
U.S. Physical Therapy to Present at the 2017 Credit Suisse Under Followed Opportunities Conference Sep 11 2017
Edited Transcript of USPH earnings conference call or presentation 29-Jun-17 2:30pm GMT Aug 13 2017
U.S. Physical Therapy, Inc. – Value Analysis (NYSE:USPH) : August 7, 2017 Aug 07 2017
U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US :... Aug 07 2017
U.S. Physical Therapy posts 2Q profit Aug 03 2017
Investor Network: U.S. Physical Therapy, Inc. to Host Earnings Call Aug 03 2017
U.S. Physical Therapy Reports Second Quarter and Six Months 2017 Results Aug 03 2017
U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US : July... Jul 26 2017
U.S. Physical Therapy, Inc. Schedules Second Quarter 2017 Release and Conference Call for Thursday,... Jul 24 2017
ETFs with exposure to U.S. Physical Therapy, Inc. : July 13, 2017 Jul 13 2017
Earnings Review and Free Research Report: U.S. Physical Therapy's Quarterly Revenue Grew 12.3%;... Jul 13 2017
Featured Company News - US Physical Therapy Acquired Nine-Clinic Group Jul 07 2017
U.S. Physical Therapy Announces Nine-Clinic Group Acquisition Jul 05 2017
U.S. Physical Therapy, Inc. :USPH-US: Earnings Analysis: Q1, 2017 By the Numbers : July 3, 2017 Jul 03 2017
ETFs with exposure to U.S. Physical Therapy, Inc. : June 29, 2017 Jun 29 2017
U.S. Physical Therapy, Inc. First Quarter 2017 Conference Call Today Thursday, June 29, 2017 Jun 29 2017
U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US : June... Jun 29 2017
U.S. Physical Therapy Reports First Quarter Results Jun 29 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}